These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V. Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [Abstract] [Full Text] [Related]
7. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E, El-Gendi SM, Yehya A, Gowil AG. Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437 [Abstract] [Full Text] [Related]
9. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Shayanfar N, Mashayekh M, Mohammadpour M. Acta Med Iran; 2010 Dec; 48(3):142-7. PubMed ID: 21137648 [Abstract] [Full Text] [Related]
12. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. Lee SH, Lee YS, Hong YG, Kang CS. APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256 [Abstract] [Full Text] [Related]
20. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H. Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]